pindolol has been researched along with Diabetes Mellitus, Type 1 in 6 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Orthostatic hypotension is one of the most troublesome symptoms in diabetic autonomic neuropathy." | 2.66 | No effect of Pindolol on postural hypotension in type 1 (insulin-dependent) diabetic patients with autonomic neuropathy. A randomised double-blind controlled study. ( Dejgård, A; Hilsted, J, 1988) |
| "We divided the patients with IDDM into two groups based on their level of blood glycosylated hemoglobin (HbA1) when samples were taken." | 1.27 | Adaptive regulation of beta-adrenergic receptors in children with insulin dependent diabetes mellitus. ( Kuroume, T; Nagashima, K; Noji, T; Suzuki, S; Tashiro, M; Yagi, H, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwab, KO | 1 |
| Bartels, H | 1 |
| Martin, C | 1 |
| Leichtenschlag, EM | 1 |
| Yu, O | 1 |
| Ouyang, A | 1 |
| Dejgaard, A | 1 |
| Liggett, SB | 1 |
| Christensen, NJ | 1 |
| Cryer, PE | 1 |
| Hilsted, J | 2 |
| Andersen, EB | 1 |
| Lindskov, HO | 1 |
| Marving, J | 1 |
| Boesen, F | 1 |
| Beck-Nielsen, H | 1 |
| Hesse, B | 1 |
| Noji, T | 1 |
| Tashiro, M | 1 |
| Yagi, H | 1 |
| Nagashima, K | 1 |
| Suzuki, S | 1 |
| Kuroume, T | 1 |
| Dejgård, A | 1 |
1 trial available for pindolol and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
No effect of Pindolol on postural hypotension in type 1 (insulin-dependent) diabetic patients with autonomic neuropathy. A randomised double-blind controlled study.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetic Neuropathies; D | 1988 |
5 other studies available for pindolol and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Decreased beta 2-adrenoceptor density and decreased isoproterenol induced c-AMP increase in juvenile type I diabetes mellitus: an additional cause of severe hypoglycaemia in childhood diabetes?
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclic AMP; Diabetes Mellitus, Type 1; Granulocytes; Hum | 1993 |
Distribution of beta-adrenoceptor subtypes in gastrointestinal tract of nondiabetic and diabetic BB rats. A longitudinal study.
Topics: Adrenergic beta-Antagonists; Aging; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Typ | 1997 |
Adrenergic receptors are a fallible index of adrenergic denervation hypersensitivity.
Topics: Adult; Cell Membrane; Cyclic AMP; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Epinephrine; Hum | 1991 |
Decrease in beta-receptor density explaining the development of pindolol- and prenalterol-tolerance in orthostatic hypotension.
Topics: Adrenergic beta-Agonists; Diabetes Mellitus, Type 1; Drug Tolerance; Female; Humans; Hypotension, Or | 1985 |
Adaptive regulation of beta-adrenergic receptors in children with insulin dependent diabetes mellitus.
Topics: Adolescent; Adult; Cell Membrane; Child; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Hum | 1986 |